{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Distal and Standard Roux-en-Y Gastric Bypass in Patients with BMI 50\u201360 kg/m\u00b2"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In this double-blind, parallel-group RCT, 123 patients aged 20\u201360 years with a BMI of 50\u201360 kg/m\u00b2 were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "123 patients aged 20\u201360 years with a BMI of 50\u201360 kg/m\u00b2 were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either standard RYGB (150 cm alimentary limb) or distal RYGB (150 cm common channel)"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was change in BMI at 2 years."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using permuted-block randomization with allocation concealment."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, outcome assessors, and the statistician were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "123 patients aged 20\u201360 years with a BMI of 50\u201360 kg/m\u00b2 were randomised"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of 113 patients who received an intervention, 92 attended the 5-year follow-up."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "BMI reduction was 15.1 kg/m\u00b2 (95% CI 13.9 to 16.2) for standard RYGB and 15.7 kg/m\u00b2 (14.5 to 16.9) for distal RYGB, with a between-group difference of -0.64 kg/m\u00b2 (P = 0.447)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included repeat abdominal surgery in 28% of standard and 18% of distal RYGB patients."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT00821197."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: South-Eastern Norway Regional Health Authority and Alexander Malthes Foundation."
      }
    },
    "total_score": 24,
    "max_score": 25
  },
  "model": "gpt-4o"
}